Featured Research

from universities, journals, and other organizations

Surprising role of gene regulator protein in development of skin tumors

Date:
November 18, 2013
Source:
Medical University of Vienna
Summary:
Findings by scientists reveal a surprising role for histone deacetylase 1 (HDAC1) – a member of a family of chromatin modifying proteins – in the development of skin tumors. The results emphasize that care must be taken when using HDAC inhibitors as anti-cancer drugs.

Divergent roles of HDAC1 and HDAC2 in the regulation of epidermal development and tumorigenesis.
Credit: EMBO Journal

Findings by scientists from the Max F. Perutz Laboratories (MFPL) of the University of Vienna and the Medical University of Vienna reveal a surprising role for histone deacetylase 1 (HDAC1) -- a member of a family of chromatin modifying proteins -- in the development of skin tumors. The results from Christian Seiser and his team also emphasize that care must be taken when using HDAC inhibitors as anti-cancer drugs.

Related Articles


Skin tumors -- when healing of scratches and cuts goes wrong

The skin is the largest organ of the human body, protecting us from dehydration and external impacts. It's a self-renewing tissue, meaning that if we hurt ourselves for example by scraping or cutting our skin, new skin cells will replace the old damaged ones and our wound will heal. On a molecular level this process is controlled by a wide range of factors, ensuring that the right number of undifferentiated progenitor cells differentiate into skin cells and make their way to replace the old damaged ones. If something goes wrong during this process, pathologies, including skin tumors, can be the consequence. And with non-melanoma skin cancers being the most frequent human tumors, there is clearly a tremendous need to understand the underlying molecular mechanisms, to allow the development of drugs to treat these types of cancer.

Chromatin or how to fit the genomic DNA in a cell's nucleus

One regulatory mechanism known to be involved in skin development and renewal is chromatin modification. Basically, chromatin is the DNA of a cell wrapped around a barrel shaped structure of proteins -- so-called histones -- condensing the DNA so that it can actually fit within a cell's nucleus. The histones that form the barrels can be reversibly modified via the attachment of small chemical groups, which in turn regulates how tightly the DNA can be wrapped around them and therefore how condensed the chromatin is. This process controls which proteins are made in a cell at a given moment, also determining in the early stages of life which cells develop into muscle cells, brain cells or skin cells for example. In self-renewing tissues, such as the skin, chromatin modification is also involved in regulating the replacement of old or damaged cells in later stages in life.

Targeting HDACs to treat cancer

One type of chromatin modifiers is called histone deacetylase (HDAC), of which 18 variants are known in humans. HDAC inhibitors are already approved for cancer treatment but most of these drugs are not specific and act on several HDAC variants. This is a problem, as inhibiting the wrong variant can actually accelerate cancer progression as the team of Christian Seiser at the MFPL and the Medical University of Vienna has now shown. In a project supported by the Austrian Genome research program GEN-AU they looked at the two variants, HDAC1 and HDAC2, which based on previous results were promising targets for tumor therapy and are known to have redundant functions. "When we ablated the function of either of these proteins in the skin of a mouse model system it had no obvious effect.

However, when we ablated HDAC1 function completely and HDAC2 function partly we saw severe developmental defects and the spontaneous development of skin tumors," explains Christian Seiser. They further investigated this phenotype in a skin tumor model system, provided by Maria Sibilia from the Institute for Cancer Research of the Medical University of Vienna, and found that deactivating HDAC1 actually accelerates tumor development, while HDAC2 deactivation has no effect.

These results came as a big surprise for the researchers, who had initially thought that deactivating or inhibiting HDAC1 would halt cancer progression, but found that in skin cancer the opposite is true. Christian Seiser says: "Our results highlight that it is crucial to understand the individual role the various HDAC variants in different cell types and hence different types of cancer, before HDAC inhibitors can be used safely as therapeutics."


Story Source:

The above story is based on materials provided by Medical University of Vienna. Note: Materials may be edited for content and length.


Journal Reference:

  1. Mircea Winter, Mirjam A Moser, Dominique Meunier, Carina Fischer, Georg Machat, Katharina Mattes, Beate M Lichtenberger, Reinhard Brunmeir, Simon Weissmann, Christina Murko, Christina Humer, Tina Meischel, Gerald Brosch, Patrick Matthias, Maria Sibilia, Christian Seiser. Divergent roles of HDAC1 and HDAC2 in the regulation of epidermal development and tumorigenesis. The EMBO Journal, 2013; DOI: 10.1038/emboj.2013.243

Cite This Page:

Medical University of Vienna. "Surprising role of gene regulator protein in development of skin tumors." ScienceDaily. ScienceDaily, 18 November 2013. <www.sciencedaily.com/releases/2013/11/131118080922.htm>.
Medical University of Vienna. (2013, November 18). Surprising role of gene regulator protein in development of skin tumors. ScienceDaily. Retrieved November 29, 2014 from www.sciencedaily.com/releases/2013/11/131118080922.htm
Medical University of Vienna. "Surprising role of gene regulator protein in development of skin tumors." ScienceDaily. www.sciencedaily.com/releases/2013/11/131118080922.htm (accessed November 29, 2014).

Share This


More From ScienceDaily



More Health & Medicine News

Saturday, November 29, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Rural India's Low-Cost Sanitary Pad Revolution

Rural India's Low-Cost Sanitary Pad Revolution

AFP (Nov. 28, 2014) — One man hopes his invention -– a machine that produces cheap sanitary pads –- will help empower Indian women. Duration: 01:51 Video provided by AFP
Powered by NewsLook.com
Research on Bats Could Help Develop Drugs Against Ebola

Research on Bats Could Help Develop Drugs Against Ebola

AFP (Nov. 28, 2014) — In Africa's only biosafety level 4 laboratory, scientists have been carrying out experiments on bats to understand how virus like Ebola are being transmitted, and how some of them resist to it. Duration: 01:18 Video provided by AFP
Powered by NewsLook.com
WHO Says Male Ebola Survivors Should Abstain From Sex

WHO Says Male Ebola Survivors Should Abstain From Sex

Newsy (Nov. 28, 2014) — WHO cites four studies that say Ebola can still be detected in semen up to 82 days after the onset of symptoms. Video provided by Newsy
Powered by NewsLook.com
Ebola Leaves Orphans Alone in Sierra Leone

Ebola Leaves Orphans Alone in Sierra Leone

AFP (Nov. 27, 2014) — The Ebola epidemic sweeping Sierra Leone is having a profound effect on the country's children, many of whom have been left without any family members to support them. Duration: 01:02 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins